Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;7(Suppl 8):S351.
doi: 10.21037/atm.2019.09.80.

Is serotonin pathology a good biomarker in vivo for early Parkinson's disease?

Celia Painous  1   2   3   4 , Andres Perissinotti  5 , Maria J Martí  1   2   3   4
Affiliations
Editorial

Is serotonin pathology a good biomarker in vivo for early Parkinson's disease?

Celia Painous et al. Ann Transl Med. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies. Nature 1997;388:839-40. 10.1038/42166 - DOI - PubMed
    1. Halliday GM, Li YW, Blumbergs PC, et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson’s disease. Ann Neurol 1990;27:373-85. 10.1002/ana.410270405 - DOI - PubMed
    1. Hartmann A. Postmortem studies in Parkinson’s disease. Dialogues Clin Neurosci 2004;6:281-93. - PMC - PubMed
    1. Kish SJ, Tong J, Hornykiewicz O, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson’s disease. Brain 2008;131:120-31. - PubMed
    1. Pagano G, Politis M. Molecular Imaging of the Serotonergic System in Parkinson’s Disease. Int Rev Neurobiol 2018;141:173-210. 10.1016/bs.irn.2018.08.002 - DOI - PubMed